AI
VCYT icon

Atria Investments’s Veracyte VCYT Stock Holding History

Atria Investments’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$407K Sell
6,928
-612
-8% -$25.7K ﹤0.01% 1643
2026
Q1 		$243K Buy
7,540
+1,081
+17% +$40K ﹤0.01% 1879
2025
Q4 		$272K Sell
6,459
-205
-3% -$8.26K ﹤0.01% 1792
2025
Q3 		$229K Buy
+6,664
New +$191K ﹤0.01% 1873

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Atria Investments's VCYT Position: Q2 2026 in Review

Atria Investments reduced its Veracyte (VCYT) stake by 8.1% in Q2 2026, selling an estimated $25.7K and leaving 6,928 shares worth $407K. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Atria Investments first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Atria Investments held 6,928 shares of Veracyte worth $407K as of Q2 2026.
  • Atria Investments sold 612 Veracyte shares in Q2 2026, an estimated $25.7K.
  • Veracyte made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1643 holding.
  • Atria Investments first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.